Company Chalice Brands Ltd. Canadian Securities Exchange
Equities
CHAL
CA15756R1047
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Oregon
92.1
%
| 19 | 91.1 % | 27 | 92.1 % | +42.15% |
Other
5.4
%
| 0 | 1.2 % | 2 | 5.4 % | +520.26% |
Nevada Wholesale
2.4
%
| 2 | 7.7 % | 1 | 2.4 % | -55.44% |
Sales per region
CAD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 29 | 100.0 % | +40.57% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,415,725 | 66,558,772 ( 78.85 %) | 0 | 78.85 % |
Company contact information
![address Chalice Brands Ltd.(CHAL)](https://cdn.zonebourse.com/static/address/123103131.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+26.93% | 5.6B | |
-33.55% | 3.53B | |
-3.74% | 3.03B | |
-26.09% | 2.58B | |
-10.93% | 2.31B | |
+41.50% | 1.86B | |
+41.84% | 1.45B | |
+47.62% | 1.41B | |
-28.07% | 1.27B |